The Medical Aesthetic Injectable Summit (MAIS) invites physicians, academics, and industry professionals dedicated to aesthetic injectables on October 4 & 5, 2024. This event provides a platform for leaders to discuss the science, innovations, market trends, and business aspects of current and future toxins and dermal fillers. From clinician discussions on practice consensus to AI-powered speed matching for finding the right networking partners, MAIS is the first summit to bring together the entire microcosm of injectables. 📔 Check out the full program: https://lnkd.in/g9D4mzeJ 🐣 Register with Early Bird rates: https://lnkd.in/g-2GfP6h 👉 Interested in sponsoring? Find details here: https://lnkd.in/grD9__5n #mais2024 #summit #hyaluronicacid #toxins #fillers #injections #aesthetic #surgery #event #startups #business #research #science
Benjamin Ascher’s Post
More Relevant Posts
-
The Medical Aesthetic Injectable Summit (MAIS) invites physicians, academics, and industry professionals dedicated to aesthetic injectables on October 4 & 5, 2024. This event provides a platform for leaders to discuss the science, innovations, market trends, and business aspects of current and future toxins and dermal fillers. From clinician discussions on practice consensus to AI-powered speed matching for finding the right networking partners, MAIS is the first summit to bring together the entire microcosm of injectables. 📔 Check out the full program: https://lnkd.in/grhSr5sP 🐣 Register with Early Bird rates: https://lnkd.in/g8PPNhGc 👉 Interested in sponsoring? Find details here: https://lnkd.in/g__9qNPD #mais2024 #summit #hyaluronicacid #toxins #fillers #injections #aesthetic #surgery #event #startups #business #research #science
To view or add a comment, sign in
-
𝗡𝗮𝘀𝗮𝗹 𝗦𝗽𝗹𝗶𝗻𝘁𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰 - 𝟮𝟬𝟯𝟮. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁. Our latest market research report on the Nasal Splints Market provides a comprehensive analysis of this rapidly evolving sector. Delving into both quantitative and qualitative aspects, we examine manufacturers, conduct regional analysis, and explore various types and applications of Nasal Splints. From in-depth company profiles to market share estimates for leading competitors in 2024, our report equips businesses with valuable insights for strategic decision-making. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗡𝗮𝘀𝗮𝗹 𝗦𝗽𝗹𝗶𝗻𝘁𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/deAjeXkm **By Type:** Internal Nasal Splints, External Nasal Splints **By Applications:** Rhinoplasty, Septoplasty, Nasal Fracture **By Regions:** North America, Europe, Asia-Pacific, South America, Middle East & Africa **By Key Players:** Medtronic, Smith+Nephew, Stryker, Zimmer Biomet, BKK B. Braun Melsungen AG , KLS Martin Group, Intersect ENT, Inc., Now Part of Medtronic, Boston Medical Products, Inc., Summit Medical Group, Invotec International Inc, ENT Surgical Associates, Innovia Medical, Eagle Labs, Inc., Rhinostics Inc. #nasalsplints #medicaldevices #marketresearch #globalmarket #healthcare #rhinoplasty #septoplasty #nasalfracture #surgery #medicaltechnology #innovation #health #businessintelligence #strategy #marketanalysis
To view or add a comment, sign in
-
Devices we have helped bring to market 😁 🏆 Whilst we like to keep our clients confidential 😉 , here are some of the cool devices we have helped bring to market: - An artificial intelligence device used in breast cancer screening decisions - A non-surgical gastric balloon device requiring no anaesthesia or endoscopy - A haemostatic patch to stop disruptive bleeding during surgery - Lateral flows, PCRs and LAMP devices for Covid-19 testing - Insulin pumps including software - Hip implants and instrumentation - Ostomy pouches - Loads of cardiovascular catheters such as balloon dilatation catheters, ECG machines, PICCs, CVCs, haemodialysis catheters and stent grafts. I love seeing the hard work come together and see manufacturers problems solved and devices move from initial conception to commercialisation 😊 Russell Regulatory Consultants #medicaldevices #consultancy #startup #biotech #medtech
To view or add a comment, sign in
-
𝐀𝐈 𝐢𝐬 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐭𝐡𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲! 🤔Did you know that 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 is already being used to develop new drugs and therapies? AI analyzes vast amounts of data to identify potential drug targets and accelerate the drug discovery process.💭 #AI #healthcare #futureofmedicine #medicaltechnology #diagnosis #treatment #surgery #digitalhealth #machinelearning #artificialintelligence
To view or add a comment, sign in
-
𝐈𝐧𝐭𝐫𝐚𝐨𝐜𝐮𝐥𝐚𝐫 𝐋𝐞𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 $6.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭- https://lnkd.in/dfEPHGKS The global intraocular lens market growth forecasted to transform from $4.2 billion in 2023 to $6.0 billion by 2029, driven by a CAGR of 6.3%. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Alcon Inc. (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), and Bausch & Lomb (US), among others. 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 STAAR Surgical Biotech Healthcare Aurolab VSY Biotechnology Appasamy Associates Mediphacos iCare Medical Tech. EyeKon Medical, Inc. Eye Associates of New Mexico Cristalens International Cristalens Appasamy Ocular Devices (P) Ltd National Medical Supplies U.S. IOL, Inc. Tallman Eye Associates FREEDOM OPHTHALMIC PVT LTD Breyer, Kaymak & Klabe Eye Surgery Nepal Eye Program - Tilganga Institute of Ophthalmology (Official Page) I-care Group Pacific Vision Institute Northwest Eye Physicians OPTITECH EYECARE Houston Lasik & Eye AMIPLANT GmbH Agaaz Ophthalmics
To view or add a comment, sign in
-
Interspinal Fixation LESS is Simpler and Simpler is revolutionary. Get to know Inspan. -Platform of proven patented interspinous fixation technologies. -FDA-approved since 2010. -Indicated for spondylolisthesis, trauma (fracture or dislocation), tumor, degenerative disc disease (DDD) and spinal stenosis. NANISX KIC Ventures FacetFuse Sacrix NanoFUSE Biologics Inspan Sagitechnology LESS Spine MISquito AxioMed #LESS #Spine #Surgery #exposure #lessexposurespinesurgery #technologies #invented #fusion #backpain #implant #innovation #Entrepreneurship #Resilience #Innovation #Invest #surgeons #industry #medicaldevice #interspinous #stenosis Erik Spayde, MD This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.
To view or add a comment, sign in
-
#Endoscopic_Vessel_Harvesting_Market is flourishing because of growing preference for minimally invasive #surgery and increasingly rapid adoption of #technological advancements. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐭𝐨 𝐁𝐥𝐮𝐞𝐖𝐞𝐚𝐯𝐞 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 "𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐕𝐞𝐬𝐬𝐞𝐥 𝐇𝐚𝐫𝐯𝐞𝐬𝐭𝐢𝐧𝐠 (𝐄𝐕𝐇) 𝐌𝐚𝐫𝐤𝐞𝐭 " @ https://lnkd.in/dUidrwMs ⏹𝐌𝐚𝐣𝐨𝐫 𝐩𝐥𝐚𝐲𝐞𝐫𝐬: ☑Getinge, ☑Terumo Medical Corporation, ☑LivaNova, ☑KARL STORZ, ☑Saphena Medical, Inc. ☑Cardio Medical Supplies (CMS), ☑Medtronic, ☑Olympus Corporation, ☑FUJIFILM Diosynth Biotechnologies, ☑Arthrex, ☑Aesculap (US), ☑MedX Pharmacy, ☑S3V Vascular Technologies , and ☑URGIQUEST. 📢𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: The in-depth #research_report on the Global #Endoscopic_Vessel_Harvesting Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Endoscopic Vessel Harvesting (#EVH) Market, #Blueweave #Consulting #marketresearch #marketforecast #marketshare
To view or add a comment, sign in
-
Endometriosis care is evolving. Women with endometriosis have long faced limited options: hormonal treatments with side effects or invasive surgery. Both take a toll — physically, emotionally, and financially. But change is finally on the horizon. The Artemis Women's Health Foundation and Catenion have released a White Paper that highlights the growing need for non-hormonal treatment options for both Endometriosis and Adenomyosis. It serves as a guide for Startups, Investors, and Pharma companies looking to transform care and bring innovative solutions to those who need them most. At Scanvio Medical, we share this mission. Our work focuses on advancing solutions that prioritize early, accessible, and patient-focused care for women’s health. Awareness is the first step toward change. We are proud to stand alongside a community dedicated to rethinking what care for women can and should be. It is inspiring to see so many innovators driving progress, and we are excited to be part of this movement. Thank you for including us in this essential dialogue. We look forward to continuing this journey toward better health outcomes for women. 👉 Discover the full White Paper here: https://lnkd.in/e3aNdA4x #ArtemisWomensHealthFoundation #ScanvioMedical #Endometriosis #WomensHealth #MedicalInnovation #NonHormonalTreatments #AIforUltrasound #Innovation #Healthcare
What if endometriotic lesions could be removed with novel medicines instead of surgery? What if new imaging methods could replace laporoscopic surgery for the definitive diagnosis of endometriosis? What if biomarkers could diagnose endometriosis early? Did you know endometriosis affects over 10% of women during their reproductive years, significantly impacting their quality of life? Our new White Paper explores the critical need for non-hormonal treatment options for endometriosis and adenomyosis. Despite the high prevalence, new therapies are lacking, with current treatments being either hormonal or invasive, representing a high cost to patients and society. The Artemis Women's Health Foundation and Catenion have created a comprehensive guide for startups, investors and pharma companies who want to change the status quo and bring innovative treatments to Endometriosis and Adenomyosis patients. Ready to learn more? Download our White Paper now: https://lnkd.in/e3aNdA4x #ArtemisWomensHealthFoundation #Endometriosis #WomensHealth #MedicalInnovation #NonHormonalTreatments #Adenomyosis #Innovation #Healthcare #DownloadNow Gesynta Pharma AB, Maipl Therapeutics, Inc. FimmCyte, Serac Healthcare, Hera Biotech Xena Dx (Techstars '23) Heranova Lifesciences Scanvio Medical MiMARK Diagnostics DotLab curE-me, Fiftyone Bio
To view or add a comment, sign in
-
If I failed, would another surgeon build a full platform of de novo spine technologies? Unlikely. Three traps a doctorpreneur must avoid: 1. Ego and Pride: Doctors often align with companies they view as successful, but loyalty to companies like NuVasive can lead to disappointment when they don’t endure. 2. Financial Imbalance: Surgeons contribute millions to companies but receive no support during personal challenges, highlighting an overlooked financial disparity. 3. Money and Titles: While surgery brings financial rewards, a true doctorpreneur focuses on solving problems, setting aside short-term gains and titles to create long-term impact. #LESS #Spine #lessexposurespinesurgery #technologies #fusion #implant #innovation #TDR #biologics #bonegraft #fusion #orthopedics #spine #orthopedicsurgery #painmanagement To Learn More: www.KICVentures.com www.NANISX.com www.AxioMed.com NANISX KIC Ventures FacetFuse Sacrix NanoFUSE Biologics Inspan Sagitechnology LESS Spine MISquito AxioMed This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.
To view or add a comment, sign in
-
Interspinal Fixation LESS is Simpler and Simpler is revolutionary. Get to know Inspan. -Platform of proven patented interspinous fixation technologies. -FDA-approved since 2010. -Indicated for spondylolisthesis, trauma (fracture or dislocation), tumor, degenerative disc disease (DDD) and spinal stenosis. NANISX KIC Ventures FacetFuse Sacrix NanoFUSE Biologics Inspan Sagitechnology LESS Spine MISquito AxioMed #LESS #Spine #Surgery #exposure #lessexposurespinesurgery #technologies #invented #fusion #backpain #implant #innovation #Entrepreneurship #Resilience #Innovation #Invest #surgeons #industry #medicaldevice #interspinous #stenosis Erik Spayde, MD This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.
To view or add a comment, sign in